R. Dobrescu

发表

Matrix metalloproteinase-9 (MMP-9) promoter -1562C/T functional polymorphism is associated with an increased risk to develop micropapillary thyroid carcinoma.

C. Badiu, A. Caragheorgheopol, D. Manda, 2022, Cancer biomarkers : section A of Disease markers.

Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.

C. Badiu, C. Picu, A. Caragheorgheopol, 2020, Cancer biomarkers : section A of Disease markers.

Actualities in genetics of differentiated thyroid cancer.

C. Badiu, R. Dobrescu, 2020, Acta endocrinologica.

Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.

A. Botezatu, I. Iancu, A. Plesa, 2020, Cancer biomarkers : section A of Disease markers.

NOVEL MARKERS FOR EARLY DIAGNOSIS AND PROGNOSTIC CLASSIFICATION IN MEDULLARY THYROID CARCINOMA.

R. Dobrescu, M. Băetu, 2017, Acta endocrinologica.

A 46,XX Karyotype in Men with Infertility: Two New Cases and Review of the Literature

E. Kanavakis, S. Zachaki, K. Manola, 2022, Journal of human reproductive sciences.

Methylation of tumour suppressor genes associated with thyroid cancer.

A. Botezatu, I. Iancu, O. Popa, 2019, Cancer biomarkers : section A of Disease markers.

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?

N. Karavitaki, J. Wass, J. Byrne, 2013, Clinical endocrinology.

Growth hormone deficiency in adults impacts left ventricular mechanics: a two-dimensional speckle-tracking study.

R. Mincu, D. Vinereanu, S. Mihaila, 2015, The Canadian journal of cardiology.

Adding value in thyroid cancer diagnostic: thyroglobulin and calcitonin measurement in fine needle aspirate washout

A. Caragheorgheopol, D. Niculescu, D. Manda, 2021 .